« Back
Home /
Ondansetron

Ondansetron

Manufacturer	MedChem Express
Category	Metabolism Regulation of Appetite Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10 mg
Item no.	HY-B0002B-10mg
Targets	5-HT Receptor
CASRN	99614-02-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity[1][2][3][4][5][6][7][8].
StorageTemperature	4°C (Powder, protect from light)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	293.36
Clinical_Information	Launched
Manufacturers Research_Area	Neurological Disease; Cancer
Solubility	DMSO : 10 mg/mL (ultrasonic)\|H2O : ≥ mg/mL
Manufacturers Target	5-HT Receptor
Isoform	5-HT3 Receptor
Pathway	GPCR/G Protein; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0002B-10mg-safety-datasheet.pdf